NEW YORK (GenomeWeb) – Cancer services and research network Sarah Cannon and Syapse today announced a collaboration to launch a software-based service in support of Sarah Cannon's tumor genome profiling efforts. 

The service, expected to launch in the second half of 2015, will provide Sarah Cannon's network of cancer centers access to genomic testing, best practices guidelines, and decision support. It also will allow Sarah Cannon to streamline genomic data analysis in order to improve patient outcomes and expand clinical trial options for patients, the partners said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.